These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2. Yoo HH, Lee M, Lee MW, Lim SY, Shin J, Kim DH. Planta Med; 2007 May; 73(5):444-50. PubMed ID: 17566147 [Abstract] [Full Text] [Related]
4. Pharmacokinetic compatibility of ginsenosides and Schisandra Lignans in Shengmai-san: from the perspective of p-glycoprotein. Liang Y, Zhou Y, Zhang J, Rao T, Zhou L, Xing R, Wang Q, Fu H, Hao K, Xie L, Wang G. PLoS One; 2014 May; 9(6):e98717. PubMed ID: 24922060 [Abstract] [Full Text] [Related]
6. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies. Yang C, Zhang T, Li Z, Xu L, Liu F, Ruan J, Liu K, Zhang Z. Toxicol Appl Pharmacol; 2013 Dec 15; 273(3):561-8. PubMed ID: 24120885 [Abstract] [Full Text] [Related]
7. P-glycoprotein mediated efflux in Caco-2 cell monolayers: the influence of herbals on digoxin transport. Oga EF, Sekine S, Shitara Y, Horie T. J Ethnopharmacol; 2012 Dec 18; 144(3):612-7. PubMed ID: 23064285 [Abstract] [Full Text] [Related]
8. The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672. Elsby R, Gillen M, Butters C, Imisson G, Sharma P, Smith V, Surry DD. Drug Metab Dispos; 2011 Feb 18; 39(2):275-82. PubMed ID: 21075975 [Abstract] [Full Text] [Related]
10. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats. Sugimoto H, Hirabayashi H, Kimura Y, Furuta A, Amano N, Moriwaki T. Drug Metab Dispos; 2011 Jan 18; 39(1):8-14. PubMed ID: 20962062 [Abstract] [Full Text] [Related]
11. Effect of Tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp. Qin XL, Chen X, Zhong GP, Fan XM, Wang Y, Xue XP, Wang Y, Huang M, Bi HC. Phytomedicine; 2014 Apr 15; 21(5):766-72. PubMed ID: 24462213 [Abstract] [Full Text] [Related]
12. Effects of furanocoumarins in Kampo extract-based medicines on rat intestinal absorption of CYP3A and P-glycoprotein substrate drugs in vivo. Iwanaga K, Arimune K, Miyazaki M, Shibano M, Taniguchi M, Baba K, Kakemi M. Arch Pharm Res; 2012 Jun 15; 35(6):1055-64. PubMed ID: 22870815 [Abstract] [Full Text] [Related]
13. Analysis of lignans in Schisandra chinensis and rat plasma by high-performance liquid chromatography diode-array detection, time-of-flight mass spectrometry and quadrupole ion trap mass spectrometry. Lou Z, Zhang H, Gong C, Zhu Z, Zhao L, Xu Y, Wang B, Zhang G. Rapid Commun Mass Spectrom; 2009 Mar 15; 23(6):831-42. PubMed ID: 19222029 [Abstract] [Full Text] [Related]
20. Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp. Li X, Hu J, Wang B, Sheng L, Liu Z, Yang S, Li Y. Toxicol Appl Pharmacol; 2014 Mar 01; 275(2):163-75. PubMed ID: 24380838 [Abstract] [Full Text] [Related] Page: [Next] [New Search]